Ora Biomedical, Inc. is a new pharmaceutical company launched out of the Kaeberlein Lab at the University of Washington. We built a high-throughput small molecule discovery platform to identify longevity interventions, including natural products, pharmaceuticals, and small molecule combinations at a previously unimagined scale. The foundation ofour platform is the WormBot-AI, a robotic system coupled with AI-powered analytics to perform phenotype-based screens in live animals. The WormBot-AI is robust, stable, scalable, and already in use identifying novel interventions and aging targets. Ora Biomedical holds the exclusive commercial use rights to the WormBot platform and AI software.

Ora Biomedical, Inc.

Org chart

Similar companies